Ignite Creation Date:
2025-12-25 @ 12:55 AM
Ignite Modification Date:
2026-04-09 @ 10:59 PM
Study NCT ID:
NCT05842967
Status:
COMPLETED
Last Update Posted:
2025-08-08
First Post:
2023-04-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-18
Completion Date Type:
ACTUAL
First Submit Date:
2023-04-24
First Submit QC Date:
None
Study First Post Date:
2023-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-03-03
Results First Submit QC Date:
None
Results First Post Date:
2025-08-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-21
Last Update Post Date:
2025-08-08
Last Update Post Date Type:
ACTUAL